MLYS Price Target 2026
Mineralys Therapeutics, Inc. Common Stock - Analyst target prices & consensus estimates
Current Price
$31.93
Analysts
0
Get Complete MLYS Analysis
AI insights, DCF valuation, financials, and real-time data
View Full AnalysisFrequently Asked Questions
What is the MLYS price target?
Price target data for MLYS is being updated. Wall Street analysts regularly publish price targets based on fundamental analysis and valuation models.
What is the highest MLYS price target?
High price target estimates for MLYS are available from analyst reports and research notes.
What is the lowest MLYS price target?
Low price target estimates for MLYS are published by Wall Street analysts covering the stock.
How accurate are MLYS price targets?
Analyst price targets for MLYS are estimates based on financial models and assumptions. While analysts have access to management and conduct thorough research, price targets should be one of many factors in your investment decision. Market conditions, company execution, and unforeseen events can impact actual stock performance.
How often are MLYS price targets updated?
Analysts update MLYS price targets throughout the year, typically after earnings reports, major company announcements, or significant market events. Some analysts may revise targets quarterly while others update as needed based on new information.
What is the MLYS median price target?
Median price target for MLYS is calculated from all analyst estimates and available on our dashboard.
Should I buy MLYS based on price targets?
Review analyst price targets for MLYS along with other fundamental and technical factors before making investment decisions.
What factors influence MLYS price targets?
Analysts set MLYS price targets based on factors including revenue growth projections, profit margins, competitive position, market share, management execution, industry trends, macroeconomic conditions, and valuation multiples relative to peers. Changes in these factors can lead to price target revisions.